Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy.
Dinneen E, Allen C, Strange T, Heffernan-Ho D, Banjeglav J, Lindsay J, Mulligan JP, Briggs T, Nathan S, Sridhar A, Grierson J, Haider A, Panayi C, Patel D, Freeman A, Aning J, Persad R, Ahmad I, Dutto L, Oakley N, Ambrosi A, Parry T, Kasivisvanathan V, Giganti F, Shaw G, Punwani S. Dinneen E, et al. Among authors: persad r. Diagnostics (Basel). 2022 Apr 23;12(5):1057. doi: 10.3390/diagnostics12051057. Diagnostics (Basel). 2022. PMID: 35626214 Free PMC article.
NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study.
Dinneen E, Haider A, Allen C, Freeman A, Briggs T, Nathan S, Brew-Graves C, Grierson J, Williams NR, Persad R, Oakley N, Adshead JM, Huland H, Haese A, Shaw G. Dinneen E, et al. Among authors: persad r. BMJ Open. 2019 Jun 11;9(6):e028132. doi: 10.1136/bmjopen-2018-028132. BMJ Open. 2019. PMID: 31189680 Free PMC article.
NeuroSAFE frozen section during robot-assisted radical prostatectomy: peri-operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial.
Dinneen E, Haider A, Grierson J, Freeman A, Oxley J, Briggs T, Nathan S, Williams NR, Brew-Graves C, Persad R, Aning J, Jameson C, Ratynska M, Ben-Salha I, Ball R, Clow R, Allen C, Heffernan-Ho D, Kelly J, Shaw G. Dinneen E, et al. Among authors: persad r. BJU Int. 2021 Jun;127(6):676-686. doi: 10.1111/bju.15256. Epub 2021 Mar 29. BJU Int. 2021. PMID: 32985121 Clinical Trial.
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer.
Dinneen E, Grierson J, Almeida-Magana R, Clow R, Haider A, Allen C, Heffernan-Ho D, Freeman A, Briggs T, Nathan S, Mallett S, Brew-Graves C, Muirhead N, Williams NR, Pizzo E, Persad R, Aning J, Johnson L, Oxley J, Oakley N, Morgan S, Tahir F, Ahmad I, Dutto L, Salmond JM, Kelkar A, Kelly J, Shaw G. Dinneen E, et al. Among authors: persad r. Trials. 2022 Jul 22;23(1):584. doi: 10.1186/s13063-022-06421-7. Trials. 2022. PMID: 35869497 Free PMC article.
Re: What is the role of NeuroSAFE in robotic radical prostatectomy?
Dinneen E, Haider A, Grierson J, Briggs T, Persad R, Oakley N, Freeman A, Shaw G. Dinneen E, et al. Among authors: persad r. J Robot Surg. 2019 Oct;13(5):707-708. doi: 10.1007/s11701-019-00962-x. Epub 2019 Apr 12. J Robot Surg. 2019. PMID: 30980228 No abstract available.
NeuroSAFE PROOF Randomised Controlled Feasibility Study: Brief Report of Perioperative Outcomes, Histological Concordance, and Feasibility.
Dinneen E, Haider A, Freeman A, Oxley J, Briggs T, Nathan S, Kelly J, Grierson J, Allen C, Persad R, Aning J, Oakley N, Ahmad I, Dutto L, Shaw G. Dinneen E, et al. Among authors: persad r. Eur Urol. 2020 Sep;78(3):476-478. doi: 10.1016/j.eururo.2020.03.052. Epub 2020 Apr 25. Eur Urol. 2020. PMID: 32340693 Clinical Trial. No abstract available.
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.
Stavrinides V, Syer T, Hu Y, Giganti F, Freeman A, Karapanagiotis S, Bott SRJ, Brown LC, Burns-Cox N, Dudderidge TJ, Bosaily AE, Frangou E, Ghei M, Henderson A, Hindley RG, Kaplan RS, Oldroyd R, Parker C, Persad R, Rosario DJ, Shergill IS, Echeverria LMC, Norris JM, Winkler M, Barratt D, Kirkham A, Punwani S, Whitaker HC, Ahmed HU, Emberton M; PROMIS group. Stavrinides V, et al. Among authors: persad r. Eur Urol. 2021 Jan;79(1):20-29. doi: 10.1016/j.eururo.2020.09.043. Epub 2020 Oct 10. Eur Urol. 2021. PMID: 33051065 Free PMC article.
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.
Norris JM, Carmona Echeverria LM, Bott SRJ, Brown LC, Burns-Cox N, Dudderidge T, El-Shater Bosaily A, Frangou E, Freeman A, Ghei M, Henderson A, Hindley RG, Kaplan RS, Kirkham A, Oldroyd R, Parker C, Persad R, Punwani S, Rosario DJ, Shergill IS, Stavrinides V, Winkler M, Whitaker HC, Ahmed HU, Emberton M. Norris JM, et al. Among authors: persad r. Eur Urol. 2020 Aug;78(2):163-170. doi: 10.1016/j.eururo.2020.04.029. Epub 2020 May 1. Eur Urol. 2020. PMID: 32370911 Free PMC article.
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.
Carmona Echeverria LM, Haider A, Freeman A, Stopka-Farooqui U, Rosenfeld A, Simpson BS, Hu Y, Hawkes D, Pye H, Heavey S, Stavrinides V, Norris JM, Bosaily AE, Cardona Barrena C, Bott S, Brown L, Burns-Cox N, Dudderidge T, Henderson A, Hindley R, Kaplan R, Kirkham A, Oldroyd R, Ghei M, Persad R, Punwani S, Rosario D, Shergill I, Winkler M, Ahmed HU, Emberton M, Whitaker HC. Carmona Echeverria LM, et al. Among authors: persad r. Sci Rep. 2020 Oct 14;10(1):17177. doi: 10.1038/s41598-020-73524-z. Sci Rep. 2020. PMID: 33057024 Free PMC article.
368 results